Sale!

Antiphospholipid Antibody APLA Panel Test

1,050 د.إ

-10%

The Antiphospholipid Antibody (APLA) Panel Test is a crucial diagnostic tool used in identifying antiphospholipid syndrome (APS), a disorder of the immune system that increases the risk of blood clots. This panel typically includes tests for antibodies such as lupus anticoagulant, anticardiolipin, and anti-beta2 glycoprotein I. These antibodies target phospholipids and proteins associated with the cell membrane, leading to an increased tendency for clot formation, which can result in complications such as deep vein thrombosis, stroke, or miscarriage in pregnant women.

At DNA Labs UAE, the APLA Panel Test is available for individuals who are experiencing symptoms suggestive of APS or have a history of unexplained clotting events. The test is priced at 1050 AED, offering a comprehensive evaluation to aid in the diagnosis and management of antiphospholipid syndrome. Conducted in a state-of-the-art facility, DNA Labs UAE ensures accurate and reliable results, utilizing advanced testing methodologies under the guidance of experienced professionals. This test is a crucial step towards the appropriate management of APS, enabling targeted treatments to reduce the risk of thrombotic events and improve patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANTIPHOSPHOLIPID ANTIBODY APLA PANEL Test

Test Cost: AED 1050.0

Components

  • B177 – BETA 2 GLYCOPROTEIN 1, IgG
  • B178 – BETA 2 GLYCOPROTEIN 1, IgM
  • S054 – CARDIOLIPIN ANTIBODY IgM
  • S055 – CARDIOLIPIN ANTIBODY IgG
  • H123 – LUPUS ANTICOAGULANT BY dRVVT

Sample Condition

2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form(Form 15) is mandatory.

Report Delivery

SampleMon / Thu by 9 am; Report Next day

Method

Electromechanical Clot Detection, Enzyme Immunoassay

Test Type

Autoimmune Disorders

Doctor

Gynecologist

Test Department

IMMUNOPATHOLOGY

Pre Test Information

Overnight fasting is preferred.

Test Details

The antiphospholipid antibody (APLA) panel test is a blood test used to diagnose antiphospholipid syndrome (APS). APS is an autoimmune disorder in which the immune system mistakenly produces antibodies that attack phospholipids, a type of fat found in cell membranes. This can lead to blood clot formation and other complications.

The APLA panel test measures the levels of different types of antibodies in the blood, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and anti-beta2-glycoprotein I antibodies (anti-2GPI). These antibodies are commonly found in individuals with APS.

The test is typically ordered if a person has experienced blood clots in unusual locations, recurrent miscarriages, or other symptoms suggestive of APS. It can also be used to monitor the effectiveness of treatment in individuals with APS.

The APLA panel test is usually performed on a blood sample. The blood is drawn from a vein in the arm and sent to a laboratory for analysis. Results are typically reported as positive or negative for each type of antibody.

A positive result on the APLA panel test indicates the presence of antiphospholipid antibodies and suggests a diagnosis of APS. However, a positive result does not necessarily mean that a person has APS, as these antibodies can also be found in other autoimmune disorders or as a result of certain medications. Therefore, a positive result should be interpreted in the context of the individual’s clinical history and other test results.

It is important to note that the APLA panel test should be interpreted by a healthcare professional with expertise in autoimmune disorders.

Treatment for APS may involve blood thinners or other medications to prevent blood clots and manage symptoms.

Test Name ANTIPHOSPHOLIPID ANTIBODY APLA PANEL Test
Components *B177* BETA 2 GLYCOPROTEIN 1, IgG *B178* BETA 2 GLYCOPROTEIN 1, IgM *S054* CARDIOLIPINANTIBODYIgM *S055* CARDIOLIPINANTIBODYIgG *H123* LUPUS ANTICOAGULANT BY dRVVT
Price 1050.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen&\n3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form(Form 15) is mandatory.
Report Delivery SampleMon / Thu by 9 am; Report Next day
Method Electromechanical Clot Detection, Enzyme Immunoassay
Test type Autoimmune Disorders
Doctor Gynecologist
Test Department: IMMUNOPATHOLOGY
Pre Test Information Overnight fasting is preferred.
Test Details

The antiphospholipid antibody (APLA) panel test is a blood test used to diagnose antiphospholipid syndrome (APS). APS is an autoimmune disorder in which the immune system mistakenly produces antibodies that attack phospholipids, a type of fat found in cell membranes. This can lead to blood clot formation and other complications.

The APLA panel test measures the levels of different types of antibodies in the blood, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and anti-beta2-glycoprotein I antibodies (anti-2GPI). These antibodies are commonly found in individuals with APS.

The test is typically ordered if a person has experienced blood clots in unusual locations, recurrent miscarriages, or other symptoms suggestive of APS. It can also be used to monitor the effectiveness of treatment in individuals with APS.

The APLA panel test is usually performed on a blood sample. The blood is drawn from a vein in the arm and sent to a laboratory for analysis. Results are typically reported as positive or negative for each type of antibody.

A positive result on the APLA panel test indicates the presence of antiphospholipid antibodies and suggests a diagnosis of APS. However, a positive result does not necessarily mean that a person has APS, as these antibodies can also be found in other autoimmune disorders or as a result of certain medications. Therefore, a positive result should be interpreted in the context of the individual’s clinical history and other test results.

It is important to note that the APLA panel test should be interpreted by a healthcare professional with expertise in autoimmune disorders. Treatment for APS may involve blood thinners or other medications to prevent blood clots and manage symptoms.